Oklahoma Wesleyan University Selects BIO-key's PortalGuard Identity-as-a-Service (IDaaS) Platform to Provide Secure, Frictionless Access to Enterprise Applications

Wall, NJ  November 1, 2021 - BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced Oklahoma Wesleyan University (OKWU), in Bartlesville, OK, has selected BIO-key's PortalGuard® Identity-as-a-Service (IDaaS) platform to provide secure, frictionless identity and access management to its enterprise applications. The addition of OKWU adds to  PortalGuard’s higher education installed base of over 200 institutions across the U.S.

OKWU sought a new access management platform to enhance its IAM security and to streamline and improve the user experience when accessing enterprise applications and institutional data. Following a review of alternative solutions, OKWU’s IT team selected PortalGuard IDaaS because it satisfied important project goals of enhanced data security and reliability; provides an easy-to-use, frictionless user interface; and delivers seamless integration to critical applications, all with lower IT resource costs.

Importantly, PortalGuard IDaaS provides broad support for Multi-Factor Authentication (MFA), along with Self-Service Password Reset (SSPR) and Single Sign-On (SSO) capabilities and is quick and easy to deploy in the cloud.

PortalGuard's policy-driven password security and MFA ensures that only authorized OKWU faculty, staff, alumni, and students are able to access enterprise applications by entering just one set of credentials. This dramatically increases the satisfaction and productivity of all users, while keeping data secure.

"The PortalGuard IDaaS product is simple to install and integrate into our customers’ environment while providing a sophisticated, secure solution with an easy-to-use interface allowing staff and students to adopt it without any difficulty," said Mark Cochran, President of BIO-key - PortalGuard. "PortalGuard asserts the appropriate levels of IAM security controls to secure data while also providing accelerated time to value and integrity to the modern enterprise, which why it is an increasingly adopted, award-winning single sign-on and identity management platform."

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multifactor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key: 

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/

LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international

Twitter – Corporate: @BIOkeyIntl

Twitter – Investors: @BIO_keyIR

StockTwits: BIO_keyIR   

BIO-key Media Contact:

Erin Knapp

Matter Communications

BIO-key@matternow.com  

914-260-3158 

Investor Contacts:

William Jones, David Collins

Catalyst IR

BKYI@catalyst-ir.com 

212-924-9800

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. The content was purely for informational purposes only and not intended to be investing advice.